Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
1 Recent advances in the discovery of GSK-3 inhibitors and a
perspective on their utility for the treatment of Alzheimer’s
Robert G. Gentles, Shuanghua Hu,
and. Gene Dubowchik
2 Advances in the Development of Nitric Oxide Synthase Inhibitors
Shawn Maddaford, Subhash
Annendi, Jailall Remnauth, and
3 Small Molecule Protein–Protein Interaction Inhibitors as
Therapeutic Agents for Neurodegenerative Diseases: Current
Progress and Future Hurdles
Simon Haydar and Warren Hirst
4 Case History: Chantix (varenicline tartrate) a Nicotinic Partial
Agonist Aid to Smoking Cessation
Jotham W. Coe, Hans Rollema and
Brian T. O’Neill
5 Case History on Tekturna® /Rasilez® (Aliskiren), a Highly
Efficacious Direct Oral Renin Inhibitor as a New Therapy for
Juergen Maibaum and David Feldman
6 Advances in Vasopressin Receptor Agonists and Antagonists Thomas Ryckmans
7 The Emergence of GPR119 Agonists as Anti-diabetic Agents Robert Jones
8 Non-peptide Ligands for the Gonadotropin Receptors Nicole van Straten, Marco Timmers
9 Recent Advances in Coagulation Serine Protease Inhibitors
Mimi Quan and Joanne Smallheer
10 Advances in the Discovery of Anti-Inflammatory FMS Inhibitors Mark Player and Carl Manthey
11 Recent Advances in the Discovery of CB2 Selective Agonists Jayant Thatte, Sangdon Han, and Rob Jones
12 Advances in the Discovery of Small Molecule JAK3 Inhibitors Stephen Wrobleski
13 Recent Advances in Adenosine Receptor (AR) Ligands in
Jeff Zablocki and Rao Kalla
14 Recent Progress in the Development of Small Molecule Inhibitors
of Insulin-like Growth Factor Receptor (IGF-1R) Kinase Dinesh Vyas and Mark Wittman
15 Case History: Discovery of Ixabepilone (IXEMPRA[TM]), a First-inclass
Epothilone Analogue for Treatment of Metastatic Breast Cancer
Robert M. Borzilleri and Gregory D.
16 Hedgehog Signaling Pathway Inhibitors as Cancer Therapeutics Stefan Peuker and Karen Miller-Moslin
17 Emerging Therapies Based on Inhibitors of Phosphatidyl-Inositol-
John M. Nuss, Amy Lew Tsuhako
and Neel K. Anand Exelixis
18 Anti-infective Activity of Artemisinin and its Semi-synthetic
Derivatives John G. D'Angelo
19 Recent Advances in the Inhibition of Bacterial Type II
Greg Bisacchi & Jacques Dumas
20 Progress Towards the Discovery and Development of Specifically
Targeted Inhibitors of Hepatitis C Virus
Nicholas A. Meanwell John F.
Kadow and Paul M. Scol
21 Inhibitors of Nuclear Hormone Receptor/Steroid Receptor
Terry Moore, John Katzenellenbogen
22 Safety Testing of Drug Metabolites Tom Thompson
23 A Path to Innovation: Gene Knockouts Model New Drug Action Brian Zambrowicz
24 Discovery of Novel Positron Emission Tomography (PET) Tracers Dennis McCarthy
25 The Use of Isotopically Labeled Compounds in Drug Discovery (Chad) Charles S. Elmore
26 Mechanism based inhibition of CYP3A4 and other cytochromes P450 Bernard Murray
27 Nonclinical Toxicogenomics in the Pharmaceutical Environment Bruce D. Car
28 To Market, To Market 2008 Shridhar Hegde and Michelle Schmidt
Annual Reports in Medicinal Chemistry provides timely and critical reviews of important topics in medicinal chemistry together with an emphasis on emerging topics in the biological sciences, which are expected to provide the basis for entirely new future therapies.
- Covers findings related to cardiovascular, inflammation, and pulmonary diseases
Examines issues in oncology, from mTor inhibitors to drug targets
Incorporates up-to-date information on drug design and discovery, including delivery to market
medicinal, pharmaceutical, and organic chemists
- No. of pages:
- © Academic Press 2009
- 26th October 2009
- Academic Press
- Paperback ISBN:
- eBook ISBN:
Neuroscience Discovery Chemistry, Bristol-Myers Squibb, USA
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.